Skip to main content
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1996 May;3(3):361–362. doi: 10.1128/cdli.3.3.361-362.1996

Time to peak serum antibody response to influenza vaccine in the elderly.

P A Gross 1, C Russo 1, M Teplitzky 1, S Dran 1, P Cataruozolo 1, G Munk 1
PMCID: PMC170348  PMID: 8705685

Abstract

The earliest time at which serum antibody peaks following administration of influenza virus vaccine in elderly persons is not clearly defined. We compared the time intervals of 2 and 4 weeks after vaccination. A commercial trivalent vaccine containing the hemagglutinins of influenza viruses A/Texas/36/91(H1N1), A/Shangdong/9/93(H3N2), and B/Panama/45/90 was used. The hemagglutination inhibition antibody titers at 2 weeks after vaccination were identical to the hemagglutination inhibition antibody titers at 4 weeks for all three vaccine components.

Full Text

The Full Text of this article is available as a PDF (142.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Clements M. L., Murphy B. R. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. J Clin Microbiol. 1986 Jan;23(1):66–72. doi: 10.1128/jcm.23.1.66-72.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Foy H. M., Cooney M. K., McMahan R. A Hong Kong influenza immunity three years after immunization. JAMA. 1973 Nov 12;226(7):758–761. [PubMed] [Google Scholar]
  3. Gross P. A., Davis A. E. Neutralization test in influenza: use in individuals without hemagglutination inhibition antibody. J Clin Microbiol. 1979 Sep;10(3):382–384. doi: 10.1128/jcm.10.3.382-384.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gross P. A., Ennis F. A., Gaerlan P. F., Denson L. J., Denning C. R., Schiffman D. A controlled double-blind comparison of reactogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children. J Infect Dis. 1977 Nov;136(5):623–632. doi: 10.1093/infdis/136.5.623. [DOI] [PubMed] [Google Scholar]
  5. Rastogi S., Gross P. A., Bonelli J., Dran S., Levandowski R. A., Russo C., Weksler M. E., Kaye D., Levison M., Abrutyn E. Time to peak serum antibody response to influenza vaccine. Clin Diagn Lab Immunol. 1995 Jan;2(1):120–121. doi: 10.1128/cdli.2.1.120-121.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES